Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Active as of 2022-05-28 |
Generated Narrative: EvidenceVariable 32143
version: 13; Last updated: 2023-12-06 21:24:16+0000
Profile: VariableDefinition
identifier: FEvIR Object Identifier/32143, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.39
version: 2.0.0-ballot
name: OutcomeVariable_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control_at_5_years
title: OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years
status: Active
date: 2022-05-28 12:16:43+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description:
The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
author: Brian S. Alper:
Type | Citation |
Cite As | OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 32143. Revised 2022-05-28. Available at: https://fevir.net/resources/EvidenceVariable/32143. Computable resource at: https://fevir.net/resources/EvidenceVariable/32143. |
actual: true
handling: dichotomous variable